In a 55-year-old man with no past medical history who presents with fever of 39 °C, chills, and 12‑hour dysuria, and whose urinalysis shows pyuria, which intravenous antibiotic should be administered empirically?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Empiric Intravenous Antibiotic for Acute Pyelonephritis

For this 55-year-old man with acute pyelonephritis (fever 39°C, chills, dysuria, pyuria), you should administer either piperacillin/tazobactam (E) or amikacin (C) intravenously as empiric therapy.

Clinical Reasoning

This patient presents with classic acute pyelonephritis: high fever (39°C), chills, dysuria, and pyuria. While technically this could be "uncomplicated" pyelonephritis (no stated comorbidities), the fact that he is male automatically classifies this as a complicated UTI 1. The 2024 European Association of Urology guidelines explicitly state that "urinary tract infection in males" is a factor associated with complicated UTIs 1.

Guideline-Based Antibiotic Selection

For Uncomplicated Pyelonephritis Requiring Hospitalization

The 2024 EAU guidelines recommend initial IV therapy with 1:

  • Fluoroquinolones (ciprofloxacin 400 mg IV twice daily, levofloxacin 750 mg IV daily)
  • Aminoglycosides with or without ampicillin (amikacin 15 mg/kg daily, gentamicin 5 mg/kg daily)
  • Extended-spectrum cephalosporins (ceftriaxone 1-2 g daily, cefepime 1-2 g twice daily)
  • Extended-spectrum penicillins (piperacillin/tazobactam 2.5-4.5 g three times daily)

For Complicated UTIs with Systemic Symptoms

Since this is a male patient (complicated UTI), the guidelines recommend 1:

  • Amoxicillin plus an aminoglycoside
  • Second-generation cephalosporin plus an aminoglycoside
  • IV third-generation cephalosporin

Analysis of Answer Choices

A) Norfloxacin - Not appropriate. This is an oral fluoroquinolone not listed in parenteral regimens for pyelonephritis 1.

B) Clindamycin - Incorrect. Clindamycin has no role in empiric UTI treatment; it lacks adequate gram-negative coverage for typical uropathogens (E. coli, Klebsiella, Proteus) 1.

C) Amikacin - Correct option. Listed as appropriate empiric IV therapy at 15 mg/kg daily 1. Provides excellent gram-negative coverage including resistant organisms.

D) Moxifloxacin - Not recommended. While moxifloxacin is a fluoroquinolone, it is not listed in the EAU guidelines for pyelonephritis treatment 1. The recommended IV fluoroquinolones are ciprofloxacin and levofloxacin. Moxifloxacin appears only in the context of urethritis treatment for Mycoplasma genitalium 1.

E) Piperacillin/tazobactam - Correct option. Explicitly listed as appropriate empiric IV therapy at 2.5-4.5 g three times daily 1.

Practical Considerations

Why Both C and E Are Acceptable

Piperacillin/tazobactam advantages:

  • Broad gram-negative and gram-positive coverage
  • Covers Pseudomonas and Enterococcus (more common in male UTIs) 1
  • Can be used as monotherapy
  • Appropriate for complicated UTIs in males where prostatitis cannot be excluded 1

Amikacin advantages:

  • Once-daily dosing
  • Excellent for resistant organisms
  • Cost-effective
  • However, guidelines note it is "not studied as monotherapy" for acute uncomplicated pyelonephritis 1

Critical Pitfalls to Avoid

  1. Don't use fluoroquinolones empirically if local resistance exceeds 10% or if the patient has used fluoroquinolones in the last 6 months 1. The guidelines specifically warn against fluoroquinolone use in urology department patients.

  2. Male UTIs require longer treatment: 14 days when prostatitis cannot be excluded 1. This patient needs imaging to rule out prostatic involvement.

  3. Obtain urine culture before starting antibiotics - mandatory in all pyelonephritis cases 1. Blood cultures should also be considered given the high fever and systemic symptoms.

  4. Imaging is essential: Ultrasound should be performed to rule out obstruction, especially in males with UTI 1. If fever persists after 72 hours or clinical deterioration occurs, obtain CT imaging immediately 1.

Best Answer for This Question

Between options C and E, piperacillin/tazobactam (E) is the superior choice because:

  • It provides monotherapy coverage (amikacin typically requires combination therapy)
  • It covers the broader spectrum of pathogens seen in male complicated UTIs
  • It addresses potential prostatic involvement
  • The guidelines list it without caveats, whereas amikacin is noted as "not studied as monotherapy" 1

However, amikacin (C) remains an acceptable alternative, particularly if combined with ampicillin as recommended for complicated UTIs 1.

References

Related Questions

A 60-year-old patient presenting with dysuria, fever, urinary urgency, and frequency for one day—what antibiotic should be prescribed?
What is the appropriate outpatient treatment for an elderly patient with dysuria, pelvic pain, hematuria, urine culture growing 25,000–50,000 CFU/mL Pseudomonas aeruginosa susceptible to all antibiotics, chronic kidney disease stage 3 (eGFR ≈ 49 mL/min), hemoglobin 14.8 g/dL, and who is taking apixaban (Eliquis)?
In a 32-year-old female with costovertebral angle tenderness and urinary tract infection symptoms but no overt pyelonephritis, what is the best antibiotic?
In a 44-year-old male presenting with abdominal pain, dysuria, and urinalysis showing elevated white blood cells (5–10 cells per high-power field) and mucus, what is the appropriate antibiotic therapy?
What is the recommended treatment for acute pyelonephritis in an otherwise healthy adult?
What is the typical progression of symptoms in a 2-year-old with hand‑foot‑and‑mouth disease?
Can vitamin B1 (thiamine) reverse bone cancer?
Why is Lipok (a nutraceutical containing monacolin K) not recommended for patients over 70 years of age?
Can a ureterocele occur in a kidney with a single, non-duplicated (non-duplex) collecting system?
Given a patient with leukocytosis (white blood cell count ≈13.2 ×10⁹/L), low bicarbonate (CO₂ ≈20 mmol/L), and a mildly elevated absolute neutrophil count (≈7.8 ×10⁹/L), what is the most likely diagnosis and recommended management?
How should I evaluate and manage a patient with shortness of breath and chest pain who may have an acute infection, sepsis, and possible pulmonary embolism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.